1.Glycosphingolipid Modification: Structural Diversity, Functional and Mechanistic Integration of Diabetes.
Diabetes & Metabolism Journal 2011;35(4):309-316
Glycosphingolipids (GSLs) are present in all mammalian cell plasma membranes and intracellular membrane structures. They are especially concentrated in plasma membrane lipid domains that are specialized for cell signaling. Plasma membranes have typical structures called rafts and caveola domain structures, with large amounts of sphingolipids, cholesterol, and sphingomyelin. GSLs are usually observed in many organs ubiquitously. However, GSLs, including over 400 derivatives, participate in diverse cellular functions. Several studies indicate that GSLs might have an effect on signal transduction related to insulin receptors and epidermal growth factor receptors. GSLs may modulate immune responses by transmitting signals from the exterior to the interior of the cell. Guillain-Barre syndrome is one of the autoimmune disorders characterized by symmetrical weakness in the muscles of the legs. The targets of the immune response are thought to be gangliosides, which are one group of GSLs. Other GSLs may serve as second messengers in several signaling pathways that are important to cell survival or programmed cell death. In the search for clear evidence that GSLs may play critical roles in various biological functions, many researchers have made genetically engineered mice. Before the era of gene manipulation, spontaneous animal models or chemical-induced disease models were used.
Animals
;
Caveolae
;
Cell Death
;
Cell Membrane
;
Cell Survival
;
Cholesterol
;
Diabetes Mellitus
;
Gangliosides
;
Glycosphingolipids
;
Guillain-Barre Syndrome
;
Intracellular Membranes
;
Leg
;
Mice
;
Models, Animal
;
Muscles
;
Receptor, Epidermal Growth Factor
;
Receptor, Insulin
;
Second Messenger Systems
;
Signal Transduction
;
Sphingolipids
2.Epidermal Lipid Homeostasis.
Seung Hun LEE ; Hae Shin CHUNG ; Wook LEW
Annals of Dermatology 1995;7(2):99-111
Stratum corneum lipids, which are enriched in sphingolipids, free fatty acids, and cholesterol, are required for epidermal barrier function. When the epidermal permeability barrier is perturbed, the transepidermal water loss returns to normal by 24-48 hours in parallel with the reappearance of stratum corneum lipids, derived from secreted lamellar bodis and accelerated lipid synthesis. Recent evidence shows that topical application of individual lipids interferes with barrier recovery while complete mixtures of cholesterol, fatty acids, and ceramides facilitate recovery after barrier disrupton. Metabolic imbalances and perturbed barrier function can be either the cause or the consequences of the pathobiology of scaling disease. Many skin diseases relating cornification and dryness are indeed related to abnormality of one or several combinations of lipids. Recently the cytokines which have changed during barrier recovery seem to be important in understanding of epidermal lipid homeostasis as well as barrier recovery.
Ceramides
;
Cholesterol
;
Cytokines
;
Fatty Acids
;
Fatty Acids, Nonesterified
;
Homeostasis*
;
Permeability
;
Skin Diseases
;
Sphingolipids
;
Water
3.Altered Levels of Sphingosine and Sphinganine in Psoriatic Epidermis.
Sung Hyuk MOON ; Ju Young KIM ; Eun Hwa SONG ; Min Kyung SHIN ; Yun Hi CHO ; Nack In KIM
Annals of Dermatology 2013;25(3):321-326
BACKGROUND: Ceramides are the main lipid component of the stratum corneum and are a structurally heterogeneous and complex group of sphingolipids of which sphingoid bases are the basic structural constituents. Altered levels of sphingoid bases have been reported in skin conditions that involve dryness and barrier disruption, including atopic dermatitis. OBJECTIVE: The purpose of this study was to investigate the altered levels of sphingoid bases in psoriatic epidermis and their relationship with the clinical severity of the psoriasis. METHODS: Samples from the lesional and non-lesional epidermis were obtained from eight psoriasis patients. Levels of sphingosine and sphinganine were analyzed by high-performance liquid chromatography. The expression of ceramide synthase and ceramidase proteins, which are related to sphingosine and sphinganine metabolism, were measured using Western blot analysis. RESULTS: Levels of sphingosine and sphinganine in the lesional epidermis were significantly higher than those in the non-lesional epidermis. Although there was no altered ceramide synthase and ceramidase, there was a highly significant positive correlation between the % change of ceramidase, the degradative enzyme of ceramide into sphingosine, and the Psoriasis Area Severity Index (PASI) score. CONCLUSION: The levels of sphingosine and sphinganine were significantly increased in psoriatic epidermis and the % change of ceramidase was positively correlated with the clinical severity of psoriasis.
Blotting, Western
;
Ceramidases
;
Ceramides
;
Chromatography, Liquid
;
Epidermis
;
Humans
;
Oxidoreductases
;
Proteins
;
Psoriasis
;
Skin
;
Sphingolipids
;
Sphingosine
4.Altered Levels of Sphingosine and Sphinganine in Psoriatic Epidermis.
Sung Hyuk MOON ; Ju Young KIM ; Eun Hwa SONG ; Min Kyung SHIN ; Yun Hi CHO ; Nack In KIM
Annals of Dermatology 2013;25(3):321-326
BACKGROUND: Ceramides are the main lipid component of the stratum corneum and are a structurally heterogeneous and complex group of sphingolipids of which sphingoid bases are the basic structural constituents. Altered levels of sphingoid bases have been reported in skin conditions that involve dryness and barrier disruption, including atopic dermatitis. OBJECTIVE: The purpose of this study was to investigate the altered levels of sphingoid bases in psoriatic epidermis and their relationship with the clinical severity of the psoriasis. METHODS: Samples from the lesional and non-lesional epidermis were obtained from eight psoriasis patients. Levels of sphingosine and sphinganine were analyzed by high-performance liquid chromatography. The expression of ceramide synthase and ceramidase proteins, which are related to sphingosine and sphinganine metabolism, were measured using Western blot analysis. RESULTS: Levels of sphingosine and sphinganine in the lesional epidermis were significantly higher than those in the non-lesional epidermis. Although there was no altered ceramide synthase and ceramidase, there was a highly significant positive correlation between the % change of ceramidase, the degradative enzyme of ceramide into sphingosine, and the Psoriasis Area Severity Index (PASI) score. CONCLUSION: The levels of sphingosine and sphinganine were significantly increased in psoriatic epidermis and the % change of ceramidase was positively correlated with the clinical severity of psoriasis.
Blotting, Western
;
Ceramidases
;
Ceramides
;
Chromatography, Liquid
;
Epidermis
;
Humans
;
Oxidoreductases
;
Proteins
;
Psoriasis
;
Skin
;
Sphingolipids
;
Sphingosine
5.Analysis of ceramide metabolites in differentiating epidermal keratinocytes treated with calcium or vitamin C.
Juyoung KIM ; Hyejeong YUN ; Yunhi CHO
Nutrition Research and Practice 2011;5(5):396-403
Ceramides (Cer) comprise the major constituent of sphingolipids in the epidermis and are known to play diverse roles in the outermost layers of the skin including water retention and provision of a physical barrier. In addition, they can be hydrolyzed into free sphingoid bases such as C18 sphingosine (SO) and C18 sphinganine (SA) or can be further metabolized to C18 So-1-phosphate (S1P) and C18 Sa-1-phosphate (Sa1P) in keratinocytes. The significance of ceramide metabolites emerged from studies reporting altered levels of SO and SA in skin disorders and the role of S1P and Sa1P as signaling lipids. However, the overall metabolism of sphingoid bases and their phosphates during keratinocyte differentiation remains not fully understood. Therefore, in this study, we analyzed these Cer metabolites in the process of keratinocyte differentiation. Three distinct keratinocyte differentiation stages were prepared using 0.07 mM calcium (Ca2+) (proliferation stage), 1.2 mM Ca2+ (early differentiation stage) in serum-free medium, or serum-containing medium with vitamin C (50 microL/mL) (late differentiation stage). Serum-containing medium was also used to determine whether vitamin C increases the concentrations of sphingoid bases and their phosphates. The production of sphingoid bases and their phosphates after hydrolysis by alkaline phosphatase was determined using high-performance liquid chromatography. Compared to cells treated with 0.07 mM Ca2+, levels of SO, SA, S1P, and SA1P were not altered after treatment with 1.2 mM Ca2+. However, in keratinocytes cultured in serum-containing medium with vitamin C, levels of SO, SA, S1P, and SA1P were dramatically higher than those in 0.07- and 1.2-mM Ca2+-treated cells; however, compared to serum-containing medium alone, vitamin C did not significantly enhance their production. Taken together, we demonstrate that late differentiation induced by vitamin C and serum was accompanied by dramatic increases in the concentration of sphingoid bases and their phosphates, although vitamin C alone had no effect on their production.
Alkaline Phosphatase
;
Ascorbic Acid
;
Calcium
;
Ceramides
;
Chromatography, Liquid
;
Epidermis
;
Hydrolysis
;
Keratinocytes
;
Phosphates
;
Retention (Psychology)
;
Skin
;
Sphingolipids
;
Sphingosine
;
Vitamins
;
Water
7.Recent advances in study of sphingolipids on liver diseases.
Shao-yuan WANG ; Jin-lan ZHANG ; Dan ZHANG ; Xiu-qi BAO ; Hua SUN
Acta Pharmaceutica Sinica 2015;50(12):1551-1558
Sphingolipids, especially ceramide and S1P, are structural components of biological membranes and bioactive molecules which participate in diverse cellular activities such as cell division, differentiation, gene expression and apoptosis. Emerging evidence demonstrates the role of sphingolipids in hepatocellular death, which contributes to the progression of several liver diseases including ischaemia-reperfusion liver injury, steatohepatitis or hepatocarcinogenesis. Furthermore, some data indicate that the accumulation of some sphingolipids contributes to the hepatic dysfunctions. Hence, understanding of sphingolipid may open up a novel therapeutic avenue to liver diseases. This review focuses on the progress in the sphingolipid metabolic pathway with a focus on hepatic diseases and drugs targeting the sphingolipid pathway.
Apoptosis
;
Ceramides
;
metabolism
;
Fatty Liver
;
metabolism
;
physiopathology
;
Humans
;
Liver Diseases
;
metabolism
;
physiopathology
;
Lysophospholipids
;
metabolism
;
Reperfusion Injury
;
metabolism
;
physiopathology
;
Sphingolipids
;
metabolism
;
Sphingosine
;
analogs & derivatives
;
metabolism
8.Gangliosides in Malignancy.
Journal of the Korean Pediatric Society 1986;29(6):1-4
No abstract available.
Gangliosides*
9.Anti-apoptotic role of phospholipase D isozymes in the glutamate-induced cell death.
Kyung Ok KIM ; Kweon Haeng LEE ; Young Hoon KIM ; Seung Kiel PARK ; Joong Soo HAN
Experimental & Molecular Medicine 2003;35(1):38-45
Abstract Phospholipase D (PLD) plays an important role as an effector in a variety of physiological processes that reveal it to be a member of the signal transducing phospholipases. Recently, PLD2 was reported as a necessary intermediate in preventing apoptosis induced by hydrogen peroxide or hypoxia in rat pheochromocytoma (PC12) cells. The data presented here show that both PLD isozymes, PLD1 and PLD2 are also required in attenuating glutamate-induced cell death in PC12 cells. Treatment of PC12 cells with glutamate resulted in induction of apoptosis in these cells, which is accompanied by decreased PLD activity and increased ceramide concentration. Incubation of PC12 cells with exogenous C6-ceramide showed a time-dependent decrease of PLD activity. When cDNAs of PLD1 and PLD2 were transfected into PC12 cells respectively, overexpression of PLD1 or PLD2 resulted in inhibition of glutamate-induced apoptotic cell death. These data indicate that both PLD1 and PLD2 play a protective role against glutamate-induced cell death in PC12 cells.
Animals
;
Apoptosis/drug effects/*physiology
;
Cell Survival/drug effects
;
Ceramides/pharmacology
;
Dose-Response Relationship, Drug
;
Enzyme Activation
;
Gene Expression Regulation, Enzymologic/drug effects
;
Glutamic Acid/*toxicity
;
Isoenzymes/drug effects/genetics/*metabolism
;
Kinetics
;
PC12 Cells
;
Phospholipase D/chemistry/drug effects/genetics/*metabolism
;
Rats
;
Sphingolipids/metabolism
10.Royal jelly enhances migration of human dermal fibroblasts and alters the levels of cholesterol and sphinganine in an in vitro wound healing model.
Juyoung KIM ; Youngae KIM ; Hyejeong YUN ; Hyemin PARK ; Sun Yeou KIM ; Kwang Gill LEE ; Sang Mi HAN ; Yunhi CHO
Nutrition Research and Practice 2010;4(5):362-368
Oral administration of royal jelly (RJ) promotes wound healing in diabetic mice. Concerns have arisen regarding the efficacy of RJ on the wound healing process of normal skin cells. In this study, a wound was created by scratching normal human dermal fibroblasts, one of the major cells involved in the wound healing process. The area was promptly treated with RJ at varying concentrations of 0.1, 1.0, or 5 mg/ml for up to 48 hrs and migration was analyzed by evaluating closure of the wound margins. Furthermore, altered levels of lipids, which were recently reported to participate in the wound healing process, were analyzed by HPTLC and HPLC. Migration of fibroblasts peaked at 24 hrs after wounding. RJ treatment significantly accelerated the migration of fibroblasts in a dose-dependent manner at 8 hrs. Although RJ also accelerated the migration of fibroblasts at both 20 hrs and 24 hrs after wounding, the efficacy was less potent than at 8 hrs. Among various lipid classes within fibroblasts, the level of cholesterol was significantly decreased at 8 hrs following administration of both 0.1 ug/ml and 5 mg/ml RJ. Despite a dose-dependent increase in sphinganines, the levels of sphingosines, ceramides, and glucosylceramides were not altered with any concentration of RJ. We demonstrated that RJ enhances the migration of fibroblasts and alters the levels of various lipids involved in the wound healing process.
Administration, Oral
;
Animals
;
Ceramides
;
Cholesterol
;
Chromatography, High Pressure Liquid
;
Fatty Acids
;
Fibroblasts
;
Glucosylceramides
;
Humans
;
Mice
;
Skin
;
Sphingosine
;
Wound Healing